Identification of a Novel RUNX1::STX2 Fusion in Mixed-Phenotype Acute Leukemia (MPAL) With BCR::ABL1

Area of Science:

• Hematology
• Molecular Biology
• Oncology

Background:

• Mixed phenotype acute leukemia (MPAL) is a rare hematologic malignancy.
• MPAL with BCR::ABL1 fusion is a significant subtype, primarily affecting adult males.
• Gene fusions are critical in leukemia pathogenesis, diagnosis, and treatment.

Purpose of the Study:

• To report the first discovery of a novel RUNX1::STX2 gene fusion.
• To investigate the co-expression of RUNX1::STX2 with BCR::ABL1 in MPAL.
• To explore the potential role of this unique fusion in leukemia progression.

Main Methods:

• Case study of a patient with MPAL.
• Molecular analysis to identify gene fusions.
• Analysis of gene fusion co-expression.

Main Results:

• Identification of a novel RUNX1::STX2 gene fusion.
• Demonstration of co-expression of RUNX1::STX2 with BCR::ABL1 fusion.
• Hypothesis that RUNX1::STX2 may negatively regulate wild-type RUNX1, impacting cell differentiation.

Conclusions:

• The identified RUNX1::STX2 fusion represents a unique genetic complexity in MPAL.
• This novel fusion may contribute to leukemia development by disrupting normal hematopoietic differentiation.
• Further research is needed to elucidate the functional significance and therapeutic implications of RUNX1::STX2 in leukemia.